Much ado about nothing: Methicillin-resistant Staphylococcus aureus

T. Shannon, P. Edgar, C. Villarreal, D. N. Herndon, L. G. Phillips, John P. Heggers

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


The pathogenic methicillin-resistant Staphylococcus aureus (MRSA) has received a voluminous amount of notoriety. The four major reasons are its morbidity, mortality rate, cost of treatment, and constant appearance in intensive care units. Both Staphylococcus aureus and S. epidermidis (MRSE) account for 82% of our gram-positive wound isolates, whereas the gram- negatives account for 34% of all isolates. Therefore we compared the morbidity, mortality rate, and cost factors related to MRSA-MRSE and gram- negative infections for a 4-year period, assessing more than 214 documented infections. Morbidity and mortality rates were minor for MRSA. Pseudomonas aeruginosa and Escherichia coli accounted for 57.5% of the total gram- negative isolates. Gram-negative antimicrobial therapy usually requires two therapeutic drugs, which increases morbidity and costs, whereas the staphylococci usually can be treated by one antimicrobial. During this period there were 47 gram-negative infectious requiring 10 to 15 additional days of hospital stay, with a daily antibiotic cost of $293.40. Costs for MRSA or MRSE are 28% less. Therefore our preoccupation with MRSA or MRSE infections is unwarranted and unsubstantiated.

Original languageEnglish (US)
Pages (from-to)326-331
Number of pages6
JournalJournal of Burn Care and Rehabilitation
Issue number4
StatePublished - 1997

ASJC Scopus subject areas

  • Surgery
  • Nursing(all)
  • Emergency Medicine
  • Rehabilitation
  • Health Professions(all)


Dive into the research topics of 'Much ado about nothing: Methicillin-resistant Staphylococcus aureus'. Together they form a unique fingerprint.

Cite this